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ABSTRACT  
This study evaluated the anti-diabetic properties of the methanol extract and fractions of Dennettia tripetala leaves in alloxan diabetic rats. The 
crude  methanol extract (ME), n-hexane  (NF), ethyl acetate  (EAF), butanol  (BF) and water  (WF) fractions,  were tested for anti-diabetic 
activity in  alloxan-induced diabetic mice. The extracts and its fractions were screened for phytochemical constituents. Glibenclamide was used 
as the standard anti-diabetic treatment   Fasting blood glucose (FBG) levels were determined using a glucometer.  Lipid profile parameters 
were also assessed.  Histopathological examination of the pancreas was performed. The presence of glycosides, saponins, reducing sugars, fats 
and oil, alkaloids, carbohydrates, flavonoids, proteins and tannins were detected in ME, and the fractions. Treatment of the rats with the extract 
and its fractions reduced FBG levels significantly (p < 0.05) within 10 hours of acute treatment and 14 days short term treatment.  The highest 
reduction was by the crude extract,( ME 500 mg/kg) with percentage reduction of 62.89 %. The study revealed  significant (p < 0.05) 
reductions in serum triglyceride, serum cholesterol and LDL levels  by the extracts and its fractions  while a significant (p <  0.05) increase  in 
HDL levels was evident .  The effect of the extract and fractions on body weight indicated a moderate weight gain. Treatment with high dose of 
the extract and fractions (500 mg/kg) resulted in marked rejuvenation of the pancreatic β cells. The results of this study suggest that the leaves 
of Dennetia tripetala are endowed with potent anti-diabetic and antilipidemic properties.  
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1. INTRODUCTION 
Diabetes mellitus (DM) is a common disorder of the 
endocrine system which leads to impairment of glucose 
homeostasis resulting in severe complications such as 
retinopathy, angiopathy, nephropathy, neuropathy and 
neurological disorders [1]. It is a serious global health 
challenge characterized by hyperglycemia resulting from 
absolute or relative deficiency of insulin or by insulin 
resistance at the cellular level [2]. Features of DM may 
include lipoprotein abnormalities [3], elevated basal 
metabolic rate [4], reactive oxygen species scavenging 
enzymes deficiency [5] and damage to pancreatic beta cells 
induced by high oxidative stress [6]. Trivedi [7] reported that 
diabetes mellitus ranks seventh among the leading causes of 
death and is considered third when it’s lethal and 
debilitating complications are taken into consideration. 
Despite the tremendous achievements by pharmaceutical 
companies to produce different types of oral hypoglycaemic 
agents alongside insulin for the treatment of diabetes, there 
is still an increase in the demand of natural products with 
antidiabetic activities [8]. The use of medicinal plants as 
agents to control diabetes mellitus have been reported [9]. 
Metformin, a very effective hypoglycemic drug was 
discovered by the traditional approach, through the use of 
Galega officinialis [10]. The continuous efforts by man to 
exploit medicinal plants for the treatment of several diseases 
including diabetes is essentially because the side effects 
associated with herbal medicine are few compared to that  
associated with chemically synthesized drugs.  Dennettia 
tripetala (pepper fruit) is of Annonaceae  family. It is a 
tropical plant that is mostly dominant in West African region 
especially Cameroon, Ivory Coast and Nigeria [11, 12]. The 
plant is characterized by its pungent like spicy and pepperish 
taste, which makes it suitable for spices and condiments [13].  
Its mature fruit is masticated as a fresh green, freshly 
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ripened red, black dry fruit and dry de-hulled seed [14]. In 
Nigeria, it is locally called “Nkarika” ( Calabar),  “Ako”  (Edo), 
“Opipi”  (Idoma), “Mmimi”  (Igbo) and “Ata igbere” (Yoruba). 
The medicinal properties of the plant has been associated to 
the presence of saponins, flavonoids, tannins, alkaloids, 
terpenoids, and cyanogenic glycosides [15, 16]. Its activities 
against microbial related and coronary diseases are linked to 
the presence of these phytochemicals [17]. The leaves and 
roots have been used locally to treat various ailment 
including fever, infantile convulsion, typhoid, worm 
infestation, vomiting and stomach upset [18]. The leaf extract 
has been demonstrated to possess antimicrobial activity 
against Staphylococcus aureus. [18], antinociceptive, anti-
inflammatory, antioxidant and antimicrobial activities [19]. 
In the present study, the antidiabetic properties of Dennettia 
tripetala was assessed by evaluating the antihyperglycemic 
and hypolipidemic activities of the extract and fractions in 
alloxan- induced diabetic mice. 
2. MATERIALS AND METHODS 
2.1 Drugs and Chemicals  
The chemicals and drugs were used for this study include, 
alloxan monohydrate (Sigma LTD USA), glibendamide (NGC, 
Nigeria), methanol, n-hexane, ethyl acetate, butanol, 
chloroform, (JHD, Guangdong Guanghua Schi-Tech. Ltd  
China), formaldehyde 40 %w/v (May and Baker Ltd, 
Dagenham England), Tween-80 (Sigma Aldrich, Germany) 
DPPH,(Sigma Aldrich, Germany), ascorbic acid (Sigma 
Aldrich, Germany). total cholesterol, triglyceride, high 
density lipoprotein cholesterol kits (Randox Laboratories 
Limited, Country Atrium, United kingdom). 
2.2 Plant Materials 
Fresh leaves of Denettia tripetala were collected from Irri 
Town, Isoko South Local Government Area, Delta State, 
Nigeria. The plant was authenticated by Mr. Patrick Ugwuozo 
of the Department of Botany, Nnamdi Azikiwe University, 
Awka, with voucher number PCG/UNIZIK/0631. The fresh 
leaves were washed in a running tap to remove dust and 
other debris, and air dried for two weeks. The dried leaves 
were pulverized with electrical blender and kept in clean air 
tight amber bottle. About, 750 g of the powdered material 
was cold macerated in 80% ethanol. The mixture was 
agitated continually for two days (48 hours), and then 
filtered using Whatman filter paper No 1. The filtrate was 
concentrated to dryness using water bath at 400C. The 
extract was stored in a refrigerator before use. The 
percentage yield of the extract was calculated. 
2.3 Fractionation of Crude Extract 
Fractionation was carried out using n-hexane, ethyl acetate 
and butanol following the method described by Ihekwereme 
et al [19]. Methanol crude extract (100 g) was dispersed in 
500 ml of distill water and then poured into a separating 
funnel. N-hexane 500 ml was then added to the funnel and 
was shaken thoroughly to mix. The mixture was allowed to 
separate into two distinct layers. The n-hexane portion, 
(upper layer) was separated and the other portion was 
subjected to fresh n-hexane until the n-hexane solvent 
became clear. After the n-hexane phase, the other portion 
was subjected to ethyl acetate and butanol successively. The 
various fractions were concentrated to dryness using water 
bath at 400C.  
2.4 Experimental Animals 
A total of 100 male albino mice, (18-35 g) were purchased 
from the Laboratory Animal Facility of the Department of 
Veterinary Physiology and Pharmacology, University of 
Nigeria, Nsukka and transferred to the animal House of the 
Department of Pharmacology and Toxicology, Nnamdi 
Azikiwe University. They were housed in clean metal cages, 
with free access to water and feed (Guniea Feed®, Nigeria). 
Animals were handled in compliance with the National 
Institute of Health Guidelines for care and use of laboratory 
animals (Pub No. 85-23, revised 1985). 
2.5 Experimental Design 
 A total of 65 mice consisting of 60 diabetic mice randomized 
into 12 groups of 5 mice each and 5 non-diabetic mice and 
were treated  as follows: Group 1 (Normal control) received 
5 % Tween 80 (5 ml), Group 2 (Diabetic control)  received 5 
% Tween 80 (5 ml), Group 3  received glibenclamide (5 
mg/kg), Groups 4 and 5 received 250 and 500 mg/kg of 
methanol crude extract respectively, Groups 6 and 7 received 
250 and 500 mg/kg  of ethyl acetate fraction respectively, 
Groups 8 and 9 received 250 and 500 mg/kg  of n-hexane 
fraction respectively, Groups 10 and 11 received butanol 
fraction 250 and 500 mg/kg respectively while Groups 12 
and 13 received aqueous fraction 250 and 500 mg/kg 
respectively.  
2.6 Blood Glucose determination 
Baseline pretreatment blood glucose level (zero hour) of the 
mice was taken. Then diabetic animals were then treated as 
stated. Blood glucose level was measured at 2, 4, 6, 8 and 10 
hours post treatment using One Touch Ultramini Glucometer 
(LifeScan GmbH Switserland) [20]. Daily administration of 
glibenclamide, crude extract and fractions was also carried 
out for a period of 14 days (2 weeks) on the same animals. 
Blood glucose level was measured on day 2, 4, 6, 8, 10, 12 
and 14.  Blood samples were obtained from the tail vein of 
the mice. 
2.7 Determination of serum total cholesterol 
Serum total cholesterol (TC) was evaluated using Randox 
commercial assay kits following the methods described by 
Ezeigbo [21]. One millilitre (1 ml) of the working cholesterol 
reagent was added into tubes labeled blank, standard and 
test groups. Ten microlitres of standard cholesterol reagent, 
and samples were added into their respective tubes. They 
were mixed and allowed to stand for 10 minutes at room 
temperature. Absorbance of samples and standard were read 
with the aid of a spectrophotometer at 500 nm. Total 
cholesterol level in sample was calculated using the formula 
below;
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2.8 Determination of serum triglyceride 
Serum triglyceride was evaluated using Randox commercial 
assay kits following the methods described by Tietz [22]. 
One millilitre (1 ml) of the working triglyceride reagent was 
added into tubes labeled blank, standard and test groups. 
Ten microlitres of standard triglyceride reagent, and 
samples were added into their respective tubes. They were 
mixed and allowed to stand for 10 minutes at room 
temperature. Absorbance of samples and standard were 
read with the aid of a spectrophotometer at 500 nm. Total 
cholesterol level in sample was calculated using the formula 
below;
 
 
2.9 Determination of serum high density Lipoprotein 
cholesterol (HDL-cholesterol) 
Serum HDL-cholesterol was evaluated using Randox 
commercial assay kits following the methods developed by 
National Institute of Health Consensus Development 
Conference Statement [23]. One hundred microlitres (100 
ul) of samples and standard cholesterol reagent were 
dispensed into test tubes containing 250 ul of HDL 
cholesterol precipitate (R1). The mixture was centrifuged at 
4000 rpm for 10 minutes. Thereafter, 100 uL of samples and 
standard supernatants were added to another set of test 
tubes labeled samples and standard containing cholesterol 
reagent. The mixture was incubated for 10 minutes at room 
temperature and absorbance of standard and samples were 
measured against reagent blank at 500 nm within 60 
minutes using Spectrophotometer. HDL-cholesterol level in 
sample was calculated using the formula below;
 
 
2.10 Determination of serum low density Lipoprotein 
cholesterol (LDL-cholesterol) 
Low density lipoproteins (LDL) cholesterol in serum was 
calculated using the equation described by Friedewald et al. 
[24]. The Friedewald’s equation estimates the value of HDL-
C using the values of total cholesterol, triglyceride and HDL-
cholesterol.
 
 
2.11. Histopathological studies 
The pancreases harvested from the animals were preserved 
using 10% neutral buffered formalin placed in pre labeled 
universal containers. The pancreases were dissected and 
placed in labeled tissue cassettes and the thickness 
maintained between 3-5mm [25]. The pancreases were 
subjected to automatic tissue processing using the Leica 
TP2010 automatic tissue processor for 18 hours passing 
them through the four stages of tissue processing namely: 
fixation (using 10% neutral buffered formalin), dehydration 
(using ascending grades of isopropyl alcohol), clearing or 
dealcoholisation (using xylene) and finally impregnation or 
infiltration (using molten paraffin wax) [26]. The tissues 
were then embedded in paraffin wax using the Leica 
automated tissue embedder and sectioned to get ultra thin 
sections at five (5) microns, using the thermo scientific semi 
automated rotary microtome. The tissues were floated out 
from the thermo scientific digital floating bath on frosted 
end pre labeled slides and dried on the thermo scientific 
digital slimline hot plate. The tissues were further dried in 
the hot air oven overnight and subjected to hematoxylin and 
eosin staining to demonstrate the general tissue structure. 
Stained slides were mounted in DPX and allowed to dry 
before viewing under the microscope using X10 and X 40 
magnification. 
2.12 Statistical Analysis 
The data obtained were expressed as mean ± SD and were 
analysed using Statistical Product and Service Solutions 
(SPSS), version 20. Tests of statistical significance were 
carried out using one way Analysis of Variance (ANOVA) 
followed by post hoc turkeys test. P values < 0.05 were 
considered statistically significant. 
3. RESULTS 
3.1 Percentage yields of extract and fractions 
The yield of methanol crude extract was 200 g (26.67 %) 
while the percent yield of the fractions (w/w) were: n-
hexane (25 %), ethyl acetate (30 %), butanol (21 %) and 
water (19 %).  
3.2 Phytochemical analysis. 
The extract and fractions contained saponins, carbohydrates, 
resins, alkaloids, flavonoids, tannins, cardiac glycosides and 
reducing sugars. Flavonoids, saponins, alkaloids, and tannins 
were present in large amount in the crude extract. The ethyl 
acetate fraction contained saponins, flavonoids and tannins 
in large amount while steroids, alkaloids and cardiac 
glycosides were in moderate amount. The n hexane fraction 
had saponins, flavonoids and alkaloids in large quantity but 
is devoid of other phytoconstituents. The butanol fraction 
had terpenoids, steroids and tannins in large amounts but is 
devoid of other constituents. Water fraction contained more 
of saponins Table 1). 
3.3 Effect of crude extract and fractions on fasting blood 
glucose (FBG) level . 
The crude methanol extract and fractions reduced fasting 
blood glucose levels in alloxan- induced diabetic mice from 2 
– 10 hr  (p < 0.05). The highest reduction (62.58 %) in FBS 
was by the BF (250 mg/kg), at the 6th hour. By the 10th hour, 
a percentage reduction of 61.76 and 61.09 % was evoked by 
ME, 250 and 500 mg/kg respectively (Table 2).
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Table 1: Results of phytochemical analysis of methanol crude extract and fractions of Dennettia tripetala leaves 
  Crude extract n-haxane 
fraction 
Ethyl acetate 
fraction 
Butanol 
fraction 
Water 
fraction 
1 Saponins + + + + + +      +++ + ++ 
2 Tannins +++ ++      +++ ++ + 
3 Carbohydrates ++ +      ++ + + 
4 Reducing Sugars + +      + + + 
5 Flavonoids +++ +++      +++ + + 
7 Alkaloids ++ ++ + + - 
8 Glycosides ++ ++ ++ - + 
9 Steroids + + + + + 
10 Fats and oils ++ + + + - 
11 Proteins ++ + - - - 
12 Acidic compounds - - - - - 
(-) => Not Present, (+) => Present in small concentration, (++) => Present in moderately high concentration, (+++) => Present in 
high concentration. 
Table 2: Effect of various treatments on blood glucose level (hourly study) 
 Dose  
(mg/kg) 
FBS (mg/dl) 
  0 hr 2hr 4hr 6hr 8hr 10hr 
Normal  
control     
Tween 80 
5 ml 
100.40 ± 3.57 97.00 ± 6.50 
(3.4%) 
99.00±6.22 
(1.4%) 
89.80 ±6.49 
(10.6%) 
88.00±5.39 
(12.4%) 
96.80±10.24 
(3.6%) 
Diabetic 
control 
Tween 80 
5 ml 
447.40 ± 30.94 
 
457.60 ± 27.60 
(-2.28%) 
459.80±26.755 
(-2.77%) 
462.60 ±26.96 
(-3.39%) 
430.20 ±42.26 
(-3.89%) 
463.60±26.98 
(-3.62%) 
Glibenclamide 5   409.50 ± 
26.91 
333.90±32.28 
(18.46%) 
189.00±28.72* 
(53.85%) 
190.80±27.20* 
(53.41%) 
196.80 ±26.23* 
(51.94%) 
187±25.09* 
(54.33%) 
Methanol 
Extract 
250  497.20±53.75 
 
354.70±52.84 
(28.66%) 
195.80±50.55* 
(60.6%) 
193.50 ±48.40* 
(61.08%) 
190.09 ±44.99* 
(61.76%) 
190.00±43.50* 
(61.76%) 
500  503.80±14.63             
 
300.60±23.85* 
(40.33%) 
270.90±23.82* 
(46.23%) 
270.73 ±28.19* 
(46.26%) 
199.00 ±29.11* 
(60.50%) 
196.10±34.46* 
(61.09%) 
Ethyl acetate 
fraction 
250  386.00±27.98 
 
340.90±2742 
(11.68%) 
197.74±19.50* 
(48.77%) 
180.90±18.98* 
(53.37%) 
290.00 ±18.25* 
(24.87%) 
290.00±17.97* 
(24.87%) 
500     
503.80±96.12 
400.20±86.50 
(20.56%) 
180.00±55.96* 
(64.27%) 
190.61 ±17.00* 
(62.17%) 
211.40±20.70* 
(58.03%) 
250.00±25.62* 
(50.38%) 
n-hexane 
fraction 
250  460.60±16.92 
 
452.00±17.50 
(1.87%) 
196.70±17.01* 
(57.29%) 
180.00±17.07* 
(60.92%) 
342.00±18.06 
(25.75%) 
280.00±14.51* 
(44.41%) 
500  450.00±10.08 
 
362.00±8.97 
(19.55%) 
194.00±8.60* 
(56.89%) 
199.00 ±9.56* 
(55.77%) 
200.90 ±7.10* 
(55.35%)* 
300.00±6.41* 
(33.33% ) 
Butanol 
fraction 
250  481.40±15.95 
 
320.00±15.73* 
(33.47%) 
190.00±15.44* 
(60.53%) 
180.00 ±15.38* 
(62.58%) 
 240.00±16.62* 
(50.10%) 
290.00±15.15* 
(39.79%) 
500  480.40±4.06 
 
300.00±12.11* 
(37.58%) 
191.50±13.31* 
(60.18%) 
180.52 ±11.63* 
(62.34%) 
217.70 ±8.70* 
(54.68%) 
300.00±10.67* 
(37.55%) 
 
Water fraction 
 
250  
489.80±34.54 
 
312.00±20.53* 
(36.30%) 
200.00±19.96* 
(59.17%) 
211.00 ±18.77* 
(56.92%) 
230.00 ±18.30* 
(53.04%) 
250.00±18.66* 
(48.96%) 
500  428.60±13.17 
 
333.00±34.67* 
(22.19%) 
189.90±36.58* 
(55.69%) 
200.70±34.68* 
(53.25%) 
230.60 ±29.23* 
(46.34%) 
255.00±30.10* 
     (40.50%) 
                                                       n =5. * p < 0.05) when compared to diabetic control 
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3.4 Effect of two weeks treatment on blood glucose level 
Daily treatment with the crude methanol extract and 
fractions for 14 days reduced fasting blood glucose levels 
from the 2nd to the 14th day with the exception of ME (500 
mg/kg). Significant (p < 0.05) reduction in FBG levels was 
evident at 500 mg/kg of the extract and fractions. The 
highest reduction in FBG levels was by ME (500 mg/kg 62.89 
%), followed by BF (250 mg/kg 59.40 %) at day 14 (Table 
3). 
 
Table 3: Effect of various treatments in blood glucose level (Daily study) 
                                                              Fasting blood glucose (mg/dl) 
Treatment Dose 
(mg/k
g) 
Day 0 Day 2 Day 4 Day 6 Day 8 Day 10 Day 12 Day14 
Normal 
control                                
Tween 
80 
5 ml 
93.20±2.2
7 
89.40±10.0
9 
(4.08%) 
79.60±14.7
7 
(14.6%) 
87.20±16.8
9 
(6.4%) 
92.20± 
12.55 
(1.07%) 
78.60±9.37 
(14.6%) 
 
84. 60±2.27 
(15.7%) 
89.80±18.1
4 
(3.6%) 
Diabetic 
control 
 
,,  
395.87±31
.17 
397.54±58.
61 
(-0.42%) 
398.00±25.
94 
(-0.54%) 
399.00±26.
30 
 (-0.79%) 
400.67±26.
13 
(-1.21%) 
454.97±26.
01 
(-14.93%) 
490.89±24.
13 
(-24.00%) 
600.18±32.
66 
 (-51.61%) 
Glibenclam
ide 
5 400.00±29
.23 
 
301.00±48.
14* 
  (24.75%) 
300.00±21.
58* 
 (25.00%) 
290.00±20.
42* 
   (27.5%) 
250.00±19.
01* 
(37.5%) 
219.01±16.
14* 
(37.5%) 
190.80±20.
23* 
(52.3%) 
180.40±16.
90* 
(55.00%) 
Methanol 
Extract 
250  378.00±40
.55 
 
311.70±95.
77* 
(17.5%) 
295.40±39.
60* 
(21.85%) 
213.86±37.
25* 
(43.42%) 
193.69±39.
10* 
(49.02%) 
193.86±37.
12* 
(48.71%) 
191.56±30.
81* 
(49.32%) 
174.90±31.
93* 
(53.99%) 
500  415.00±24
.49 
 
398.40±75.
24 
  (4%) 
365.80±34.
13 
(11.85%) 
300.87±34.
42* 
(27.50%) 
209.09±37.
47* 
(49.63% 
160.00±35.
23* 
(61.45%) 
160±36.09* 
(61.45%) 
154±40.21* 
 (62.89%) 
Ethyl 
acetate 
fraction 
250  387.20±27
.93 
 
357.00±37.
42* 
(7.79%) 
330.98±16.
86* 
(14.52%) 
300.00±15.
42* 
(22.48%) 
254.78±14.
90* 
(34.19%) 
200.00±14.
66* 
  (48.35%) 
198.76±13.
25* 
(48.66%) 
172.00±17.
5* 
 (55.59%) 
500 319.09±94
.87 
 
314.98±8.4
3 
(1.28%) 
309.00±3.6
8 
(3.16%) 
210.00±5.2
5* 
(34.89%) 
200.00±6.5
8* 
(40.77%) 
189.00±8.2
1* 
(40.76%) 
180.00±9.0
4* 
 (43.59%) 
150.00±9.5
0* 
(52.99%) 
n-hexane 
fraction 
250  380.00±11
.03 
 
343.00±32.
84* 
(9.7%) 
317.00±14.
61* 
(16.58%) 
301.08±14.
33* 
(20.77%) 
217.80±19.
74* 
(42.89%) 
195.00±20.
89* 
(48.68%) 
190.09±23.
78* 
 (50.00%) 
160.00±25.
81* 
(57.89%) 
500  365.20±9.
28 
 
333.90±29.
65* 
(8.57%) 
304.44±15.
14* 
(16.64%) 
200.80±15.
96* 
(45.02%) 
199.90±16.
33* 
(45.26%) 
182.90±14.
79* 
(49.91%) 
177.00±5.1
2* 
(51.53%) 
152.00±5.5
0* 
(58.38%) 
Butanol 
fraction 
250  372.00±11
.42 
 
342.70±33.
86* 
(7.88%) 
318.89±15.
95* 
(12.39%) 
301.00±18.
36* 
(19.08%) 
299.70±20
41* 
(19.44%) 
290.89±21.
60* 
(21.80%) 
199.00±21.
78* 
(46.50%) 
151.00±22.
46* 
(59.40%) 
500  364.00±11
.71 
 
355.00±10.
97 
(2.47%) 
322.14±9.4
2* 
(11.54%) 
211.64±11.
12* 
(41.86%) 
203.90±7.6
2* 
(43.98%) 
184.00±8.3
5* 
(49.45%) 
175.00±7.9
2* 
(51.92%) 
160.00±7.3
1* 
(56.04%) 
Water 
fraction 
250  341.00±22
.09 
 
330.76±48.
48 
 (3.23%) 
330.76±21.
90 
 (3.23%) 
311.00±23.
24 
(8.7%) 
300.00±23.
22* 
(12.02%) 
292.00±23.
53* 
(14.37%) 
200.00±18.
47* 
(41.34%) 
170.89±20.
09* 
(50.4%) 
500  344.02±14
.89 
 
300.80±64.
92* 
(12.56%) 
300.00±27.
86* 
(12.79%) 
300.98±28.
53* 
(12.51%) 
200.00±28.
00* 
(41.86%) 
165.98±27.
87* 
(51.75%) 
154.98±23.
66* 
(54.95%) 
150.00±25.
02* 
(56.39%) 
 n =5. * p < 0.05) when compared to diabetic control 
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3.5 Effect on serum lipid profile 
The levels of triglyceride, total cholesterol and LDL-C were 
significantly (p < 0.05) elevated and the level of serum HDL-C 
was decreased in the diabetic control group as compared to 
normal control.  
After supplementation with methanol extract and fractions 
the alteration in lipid metabolism was significantly (p < 0.05) 
affected as evidenced by decreased serum triglyceride (TG), 
total cholesterol (TC) and LDL-cholesterol levels and 
increased HDL cholesterol concentration (Table 5) 
 
Table 5: Effect of various treatments on serum lipid profile 
Treatment Dose 
(mg/kg) 
Total cholesterol  
(mg/dl) 
Triglyceride 
 (mg/dl) 
HDL-
Cholesterol 
(mg/dl) 
LDL-Cholesterol 
(mg/dl) 
Normal control Tween 80 169.93 ±6.72 81.96 ±2.87 93.77±4.32 59.77 ±10.31 
Diabetic control Tween 80 290.00 ± 0.79 185.19±8.88 43.77 ±4.69* 108.55 ±6.65* 
Glibenclamide 5 176.28 ± 5.58 127.58±5.03 87.74 ±3.39 63.02 ±2.12 
Methanol Extract 250 171.72 ± 2.34* 88.38 ±3.59* 79.31 ±2.95* 74.74 ±2.27* 
500 170.91 ±1.71* 104.41±6.14* 87.85 ±3.93* 62.18 ±4.85* 
Ethyl acetate 
fraction 
250 150.35 ±10.37* 114.39±4.19* 82.16 ±3.60* 82.31 ±9.75* 
500 164.07 ±3.44* 133.28±11.7* 66.60 ±2.28 70.82 ±3.75* 
n-hexane 
fraction 
250 175.63 ±5.33* 119.38±4.71* 85.22 ±2.63* 66.53 ±5.58* 
500 173.35 ±0.96* 66.64 ±5.98* 84.57 ±1.81* 75.46 ±0.94* 
Butanol fraction 250 175.05 ±3.44* 83.75 ±3.03* 81.06 ±3.43* 95.24 ±4.38 
500 155.89 ±6.77* 116.89±8.43* 78.43 ±2.44* 77.08 ±7.73v 
Water fraction 250 173.35 ±0.81* 101.92±3.79* 84.57 ±1.17* 68.40 ±2.18* 
500 170.68 ±2.85* 65.23 ±0.91* 80.40 ±3.93* 80.23 ±6.18* 
 n =5. * p < 0.05 when compared to diabetic control 
 
3.6  Effect  on body weight 
There was reduction in the body weight of the animals after 
induction of diabetes with alloxan monohydrate. A 
significant (p < 0.05) increase in body weight was noticed 
after treatment with the extract and fractions (Table 6). 
 
Table 6: Effect of various treatments on body weight 
Treatments Dose (mg/kg) Weight  before 
alloxan  
Weight after 
alloxan  
Weight after 
treatment  
Change in 
weight (%) 
Normal control Tween 80 25.18±1.33 17.46±0.67 27.60±1.21     36.74 
Diabetic control Tween 80 26.88±1.64 18.00±1.05 19.20±1.07*    6.25 
Glibenclamide 5  23.72±3.05 18.06±1.14 20.20±2.59     10.59 
Extract 250 24.22±2.87 17.94±0.73 22.20±2.63      19.19 
500  28.00±1.52 17.60±0.75 24.40±1.60*       27.87 
Ethyl acetate fraction 250  30.80±1.24 18.40±1.03 27.00±1.82*        31.85 
500  24.40±2.23 19.00±1.08 22.20±2.46        14.41 
n-hexane fraction 250  23.60±1.69 18.74±0.56 23.60±1.72*        20.59 
500  26.20±2.89 19.00±1.58 22.20±2.15 14.41 
Butanol fraction 250  25.80±1.77 17.60±0.69 21.80±1.39     19.27 
500  27.80±2.40 18.20±0.66 22.60±2.84*    19.47 
Water fraction 250  26.00±1.61 19.20±0.66 22.00±1.58 12.73 
500  28.00±1.70 18.80±0.96 22.60±2.16*    16.80 
 n =5. * p < 0.05)) when compared to diabetic control 
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3.7 Histopathology 
The pancreas of the non diabetic normal control mice 
(Group 1) showed sheets of normal sized glands lined by 
columnar epithelium with basally located nuclei surrounded 
by vesicular cytoplasm. Interspersed within these glands are 
islands of normal sized Islet of Langerhans. There was 
normal pancreatic histoarchitecture of islet β cells (Figures 
1A & B). The pancreas of the diabetic mice untreated 
(Group 2)  were severely degenerated, and showed sheets of 
small sized glands lined by columnar epithelium with basally 
located nucleus and vesicular cytoplasm. No Islet of 
Langerhan was seen (Figures 1C & D). Photomicrograph of a 
pancreatic section of Group 3, (glibenclamide treated 
diabetic mice) (Figures 1E & F) revealed  normal 
histoarchitecture with  increased number of islet cells when 
compared to the untreated Group 2 that were severely 
degenerated. Histological examinations revealed a mildly 
distorted architecture of the pancreatic β cells islet of 
diabetic mice in group 4, 6, 8, 10 and 12 treated  with low 
doses (250 mg/kg) of methanol extract and different  
fractions (Figures 2C & D, 3C & D, 4C & D, 5C & D and 6C & 
D). Diabetic Groups 5 and 7 that were treated with high dose 
(500 mg/kg) of the crude extract and EF also had mildly 
despaired architecture of the pancreatic β cells islet (Figures 
2E & F, and 3E & F). Histological examinations showed a 
marked rejuvenation of the pancreatic β cells islet of diabetic 
mice in Groups 9, 11 and 13 treated with high doses (500 
mg/kg) of  HF, BF and WF  (Figures 4E & F, 5E & F and 6E & 
F) . The pancreas of all the diabetic mice (Groups 4 - 13), 
treated with the two doses of the methanol extract and 
fractions, showed clusters of variably sized regenerated Islet 
of Langerhans within sheets of normal exocrine pancreas. 
 
 
Figure 1 
 
Group 1 (Plates A and B).Pancreas of normal control group 
revealed acinar pattern structure with pyknotic nuclei of 
some acinar cells appearing.  The acinar cells which stained 
strongly are arranged in lobules with prominent nuclei. The 
islet cells are seen embedded within the acinar cells and 
surrounded by a fine capsule (arrow). Photomicrograph of 
the pancreas showed normal atrophic pancreatic islet 
Group 1 (Plates A and B) compared with Group 2 (Plates C 
and D).  Group 2 (diabetic) pancreas features showed some 
acinar cells with islet-cells showing congested pyknotic 
nuclei (short arrow) with visible Lymphocytic infiltrates 
(long arrow).  Photomicrograph of the pancreas showed 
atrophic pancreatic islet with vacuolations which indicates 
significant damaged Islets of Langerhans in the beta cells.  
Group 3 (Plates E and F) compared with Group 2 (Plates A 
and B). The pancreas of this group (Glibenclamide treated) 
revealed acinar pattern structure with pyknotic nuclei of 
some acinar cells (short arrow).  The acinar cells which 
stained strongly are arranged in lobules with prominent 
nuclei. The islet cells are seen embedded within the acinar 
cells and surrounded by a fine capsule (long arrow). 
Photomicrograph shows the regenerative effect of 
Glibenclamide (Standard drug). 
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Figure 2 
Group 4 (Plates C and D) compared with Group 2 (Plates A 
and B). The pancreas of this group (ME 250 mg/kg)  showed 
some acinar cells with islet-cells showing mildly despaired 
pyknotic nuclei (long arrow) with mild Lymphocytic 
infiltrates (short arrow). Photomicrograph reveals 
regenerative effect of the methanol extract(250 mg/kg)  
Group 5 {Plates E and F) compared with Group 2 (Plates A 
and B). The pancreas of this group (ME 500 mg/kg) showed 
some acinar cells with islet-cells showing mildly despaired 
pyknotic nuclei (long arrow) with visible Lymphocytic 
infiltrates (short arrow).The photomicrograph  shows the 
regenerative effect of methanol extract (500 mg/kg).
 
Figure 3 
Group 6 (Plates C and D) compared with Group 2 (Plates A 
and B). The pancreas of this group (EF 250 mg/kg) revealed  
secretory acini with bulky pancreatic islet (long arrow). The 
histology reveals intralobular duct at low power (short 
head). Photomicrograph showed regenerative effect of the 
ethyl acetate fraction (250 mg/kg)  
Group 7 (Plates E and F) compared with Group 2 (Plates A 
and B).  The pancreas of this group (EF 500 mg/kg)  showed 
some acinar cells with islet-cells showing mildly despaired 
pyknotic nuclei (long arrow) with mild Lymphocytic 
infiltrates (short arrow). The Photomicrograph shows the  
regenerative effect of ethyl acetate fraction (500 mg/kg).
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Figure 4 
Group 8 (Plates C and D) compared with Group 2 (Plates A 
and B).  The pancreas of this group (HF 250 mg/kg) 
reavealed  secreterory acini with bulky pancreatic islet 
(long arrow). The histology revealed intralobular duct at 
low power (short arrow). The Photomicrograph shows the 
regenerative effect of n-hexane l fraction (250 mg/kg)  
Group 9 (Plates E and F) compared with Group 2 (Plates A 
and B).  The acinar cells of this group (HF 500 mg/kg) which 
stained strongly are arranged in lobules with prominent 
nuclei. The islet cells are seen embedded within the acinar 
cells and surrounded by a fine capsule (long arrow).The 
Photomicrograph shows the regenerative effect of n-hexane 
fraction (500 mg/kg). 
 
 
Figure 5 
Group 10 (Plates C and D) compared with Group 2 (Plates A 
and B). The pancreas of this group (BF 250 mg/kg)  revealed   
secreterory acini with bulky pancreatic islet (long arrow). 
The histology reveals intralobular duct at low power (short 
arrow). The photomicrograph shows the regenerative effect 
of butanol fraction (250 mg/kg)   
Group 11 (Plates E and F) compared with Group 2 (Plates A 
and B). The pancreas of this group (BF 500 mg/kg) revealed 
acinar pattern structure with pyknotic nuclei of some acinar 
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cells appearing (short arrow).  The acinar cells which stained 
strongly are arranged in lobules with prominent nuclei. The 
islet cells are seen embedded within the acinar cells and 
surrounded by a fine capsule (long arrow). The 
photomicrograph shows the regenerative effect of butanol 
fraction (500 mg/kg). 
 
 
Figure 6 
Group 12 (Plates C and D) compared with Group 2 (Plates A 
and B). The pancreas of this group (WF 250 mg/kg)   revealed   
secretory acini with bulky pancreatic islet (long arrow). The 
histology reveals intralobular duct at low power (short 
arrow). The photomicrograph indicates the regenerative effect 
of water fraction (250 mg/kg)  
Group 13 (Plates E and F) compared with Group 2 (Plates A 
and B). The pancreas of this group (WF 500 mg/kg) revealed   
secretory acini with bulky pancreatic islet (long arrow). The 
nucleus appears pyknotic. The photomicrograph indicates the 
regenerative effect of water fraction (500 mg/kg) 
4. DISCUSSION 
In this study, the crude methanol extract and fractions of D. 
tripetala reduced fasting blood glucose levels in alloxan 
induced diabetic mice when compared to the untreated 
diabetic control. The glucose lowering effect of the extract and 
fractions may be due to the stimulation of β - cells of 
pancreatic islets [27] akin to the action of glibenclamide, a 
sulphonylurea known to produce hypoglycemic effect 
primarily through release of insulin from the pancreatic β cells 
[28]. The results of these studies are in line with previous 
report on some plants with similar phytoconstituents, which 
have been confirmed to have both, in-vivo and in-vitro anti- 
diabetic activity [29, 30, 31].  
The presence of flavonoids and saponins has previously been 
reported in ethanolic fruit extracts of L. camara which 
demonstrated hypoglycemic activity in streptozotocin induced 
diabetic male Wistar rats [32]. Flavonoids act on various 
molecular targets and regulate different signaling pathways in 
pancreatic β-cells, hepatocytes, adipocytes and skeletal 
myofibers [33]. Saponin fraction isolated from Momordica 
charantia reduced blood glucose levels and increased insulin 
secretion and glycogen synthesis in alloxan induced diabetic 
mice [34]. Diabetic dyslipidaemia is marked in alloxan induced 
diabetic mice by elevated triglycerides, total cholesterol, LDL-
C and decreased HDL-C, and  these constitute important 
cardiovascular risk factors [29]. The extract and fractions 
supplementation resulted in significant attenuation in the 
level of serum HDL-C. After supplementation with the extract 
and fractions, the alteration in lipid metabolism was 
significantly attenuated as evidenced by decreased serum 
triglyceride (TG), total cholesterol (TC), and LDL-cholesterol 
levels and increased HDL-cholesterol concentration in diabetic 
mice. These findings are in agreement with that of Kaleem et 
al. [35], who reported that the ethanolic extract of Nigella 
sativa seeds produced significant decrease in serum lipid 
profile. The reduction in serum total cholesterol concentration 
by the extract is beneficial and may reduce the risk of 
cardiovascular disease. Elevated HDL-C is very significant in 
human health because it improves the transportation of 
cholesterol from plasma to the liver for biotransformation and 
excretion, thereby preventing atheroma formation and blood 
vessel occlusion (Nwajo, 2015).  
Aja et al. [37], reported a significant (P < 0.05) decrease in the 
body weight of alloxan diabetic rats and a significant increase 
following the administration of ethanol extract of Cajanus 
cajan leaf. This is  consistent with the observation of the World 
Health Organization, that diabetes mellitus is often 
characterized by rapid and significant weight loss leading to 
fatigue which is not easily reversed. Photomicrograph of the 
pancreas showed atrophic pancreatic islet with vacuolations 
which indicates significant damaged Islets of Langerhans in 
the beta cells. The regenerative effect of the extract and 
fractions on the pancreatic cells indicate possible secretagoge 
effects on the production of insulin. The regeneration of the 
Islets of Langerhans may be due to the effect of the extract and 
fractions on the pancreatic cells, which resulted in the 
production of insulin. 
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The results of this study show that the methanol leaf extract 
and fractions of Dennettia tripetala can be used to manage 
diabetes. This confirms the local use of the plant in the 
treatment of diabetes by the indigenous people of Nigeria.  
Compliance with ethical standards 
Conflict of interest 
The authors declare that they don’t have any conflict of 
interest. 
Research involving human participants and/or animals  
Animals (albino mice) were purchased from the Laboratory 
Animal Facility of the Department of Veterinary Physiology 
and Pharmacology, University of Nigeria, Nsukka and 
transferred to the animal House of the Department of 
Pharmacology and Toxicology, Nnamdi Azikiwe University. 
They were housed in clean metal cages, with free access to 
water and feed (Guniea Feed®, Nigeria). Animals were 
handled in compliance with the National Institute of Health 
Guidelines for care and use of laboratory animals (Pub No. 85-
23, revised 1985). 
Authors Contributions 
MAO performed the experiments under the supervision of PAA 
while CUA prepared the manuscript 
REFERENCES 
1. Kristova, V., Liskoya, S., Sotnikova, S., Vojtko, R. and Kurtansky, A. 
Sulodexide improves endothelial dysfunction in streptozotocin- 
induced diabetes in rats. Physiolo Res 2008; 5: 491-494. 
2. American Diabetes Association. Diagnosis and classification of 
diabetes mellitus. Diabetes Care. 2005: 28: 37-42. 
3. Scoppola, A., Montecchi., F. R., Mezinger, G., and Lala, A. Urinary 
mevalonate excretion rate in type 2 diabetes: Role of metabolic 
control. Atherosclerosis. 2001; 156: 357-361. 
4. Owu, D. U., Antai, A. B., Udofia, K. H., Obembe, A. O., Obasi, K. O. and 
Eteng, M. U. Vitamin C improves basal metabolic rate and lipid 
profile in alloxan-induced diabetes mellitus in rats. J Biosci, 2006: 
31(5); 575-579. 
5. Kesavulu, M. M., Giri, R., Kameswara., R. B. and Apparao., C. Lipid 
peroxidation and antioxidant enzyme levels in type 2 diabetic 
with microvascular complications. Diabetic  Metab 2000; 26: 387 - 
392. 
6. Nayeemunnisa, A. Alloxan diabetes-induced oxidative stress and 
impairment of oxidative defense system in rat brain: 
neuroprotective effects of Cichorium intybus. Inter J Diabetes 
Metab. 2009; 17: 105-109. 
7. Trivedi, N. A., Majumder, B., Bhatt, J. D., and Hemavathi, K. G. Effect 
of Shilajit on blood glucose and lipid profile in alloxan– induced 
diabetic rats. Indian J Pharmacol. 2004; 36: 373-76. 
8. Venkatesh, S., Reddy, G. D., Reddy, B. M. and Ramesh. 
Antihyperglycemic activity of Carulluma attenuate. Fitoterapia. 
2003; 74: 274-277.  
9. Bailey, C. J. and Day, C., 1989. Traditional plant medicines as 
treatments for diabetes. Diabetes Care. 1989; 12: 553-564. 
10. Grover, J. K., Yadav, S., and Vats, V. Medicinal Plants of India with 
Antidiabetic Potential. J Ethnopharmacol, 2002; 81: 81-100.  
11. Hutchinson, J. and Dalziel, J. M. Flora of West Africa. Crown Agents 
for Oversea Government and Administrative mill bank, London, 
1954. pp 50–51  
12. Okiy, G. E. Indigenous Nigerian food plants. J  West Afr Sci Asso 
1960; 6: 117–121.  
13. Oyemitan, I. A. Evaluation of Dennettia tripetala G. Baker 
(Annonaleae) for central nervous system activities. Ile-Ife, Nigeria: 
Department of pharmacology, Obafemi Awolowo University; An 
M. Phil thesis. 2006.  
14. Achinewhu, S. G., Ogbonna, C. and Hard, A. D. Chemical 
composition of indigenous wild herbs, spices fruits and leafy 
vegetables used as food. Plant Food and Hum Nutr. 1995; 48: 341–
388. 
15. Lewis, K. and Ausubel F. M. Prospect for plant-derived 
antibacterials. Nat Biotechnol. 2006; 24(12): 1505–1507  
16. Nwaogu, L. A., Alisi, C. S. and Ibegulem, C. O. Evaluation of β – 
carotene content and presence of some Phytochemical in Five 
indigenous Fruits. Plant Prod Res J. 2015; 10: 13–14. 
17. Kumar, P. P., Kumaravel, S. and Lalitha, C. Screening of antioxidant 
activity, total phenol and GC–MS study of Vitex negundo. Afr J 
Biochem Res. 2010; 4(7): 191–195  
18. Oyemitan, I. A., Iwalewa, E.O., Akanmu, M. A., and Olugbade, T. A. 
Antinociceptive and anti-inflammatory effects of essential oil of 
Dennettia tripetala G. Baker (Annonaceae) in rodents. Afr J Trad 
Compl Alter Med. 2017; 5: 355–362.  
19. Ihekwereme, C. P., Chukwuson, M. A., Erhirhie, E. O. and Uche, G. O. 
(2016). Preliminary evaluation of the anti-emetic activity of crude 
methanol extract and fraction of Ocimum gratissimum. J Dev Drugs. 
2016; 5 (1): 2329-6631 
20. Salim, M. A., Imam, A. A., Dikko, A. A. U.,  Tanko, Y. and Mohammed, 
A. Effect of Aqueous Garlic (Ag) Extract of vitex sumplicifolia on 
blood glucose level, liver glycogen content, lipid profile and 
antioxidant vitamins in alloxan induced diabetic wistar rats. 
Bayero J Biomed Sci. 2016; 1(1): 179-157. 
21. Ezeigbo, I. Antidiabetic potential of methanolic leaf extracts of 
Icacina trichantha in alloxan-induced diabetic mice. Inter J 
Diabetes Dev Countr. 2010; 30(3): 150-152. 
22. Tietz, N. W. Clinical guide to Laboratory tests, Second edition W.B. 
Saunders Company, Philadelphia, USA, 2014; pp 554-556. 
23. National Institute of Health Consensus Development Conference 
Statement (NIHCDCS). Triglyceride, High Density Lipoprotein and 
Coronary Heart Disease. Washington D.C. 1992 
24. Friedewald, W. T., Levy, R. I. and Fredrickson, D. S. Estimation of 
the concentration of low-density lipoprotein cholesterol in 
plasma, without use of the preparative centrifuge. Clin Chem. 
2017; 18:499-500.  
25. Slaoui, M. and Fiette L. Histopathology procedures: From tissue 
sampling to histopathological evaluation. Methods Mol Biol. 2014; 
691: 69-82. 
26. Godwin, A. (2015). Histochemical uses of haematoxylin - A Review. 
J Phys Chem Solids. 2015; 1:24-34.  
27. Krishnakumar, K., Augusti, K. T. and Vijayammal, P. L. 
Hypoglycemic and anti-oxidant activity of Salacia oblonga wall 
extract in streptozotozin induced diabetic rats. Indian J Physiol 
Pharmacol. 2015; 43(3): 510 – 514. 
28. Agila K. N. and Kavitha, R. Antidiabetic, antihyperlipidaemic and 
antioxidant activity of Oxalis corniculata in alloxan induced 
diabetic mice. Journal of Natural Sciences Research. 2012; 2(7): 9-
17. 
29. Akah, P. A., Okoli C .O., Ibiam, A. F., Ezike A. C. and Okoye T. C. 
Evaluation of antidiabeticpotentials of Phyllanthus niruri in 
alloxan diabetic rats. Afr J Biotechnol.2010; 9: 248-259. 
30. Mbaka, G. O., Ogbonnia, S. O., Oyeniran, K. J. and Awopetu, P. I. 
Effect of Raphiahookeri seed extract on blood glucose, 
glycosylated haemoglobin and lipid profile of alloxan induced 
diabetic rats. Bri J Med Medic Res. 2015; 2(4): 621-635. 
31. Arika, W. M.,  Abdirahman, Y. A., Mawia, M. A., Wambua, K. F., 
Nyamai, D. M., Ogola, P. E., Kiboi, N. G., Nyandoro, H. O., Agyirifo, D. 
S., Ngugi M. P. and Njagi, E. N. M. In Vivo antidiabetic activity of the 
aqueous leaf extract of Croton macrostachyus in alloxan induced 
diabetic mice. Pharmaceut Analyt Acta. 2015 ;2153-2435.  
32. Piero, N. M., Kimuni, N. S., Ngeranwa, J. J. N., Orinda., G. O. and 
Njagi, J. M. Antidiabetic and Safety of Lantana rhodesiensis in 
Alloxan Induced Diabetic Rats. J Clin Biochem Nutr. 2015; 40: 163-
173. 
33. Babu, P. V., Liu, D. and Gilbert, E. R. Recent advances in 
understanding the anti-diabetic actions of dietary flavonoids. J 
Nutrl Biochem. 2013; 24: 1777-1789.  
34. Zheng, T., Shu, G., Yang Z, Mo, S., and Zhao, S. Y. Antidiabetic effect 
of total saponins from Entada phaseoloides (L.) Merr. in type 2 
diabetic rats. J  Ethnopharmacol. 2012; 13. 
35. Kaleem, M., Kirmani, D., Asif M., Ahmed, Q. and Bano, B. (2015). 
Biochemical effect of Nigella sativa L. seeds in diabetic rats. Indian 
J Expt Bio. 2015; 44:745-748. 
36. Nwajo, H. U. Efficacy of aqueous leaf extract of Vernonia 
amygdalina on plasma lipoproteins and oxidative status in 
diabetic rat model. Nig J  Physiol  Sci. 2015; 20: 39-42. 
37. Aja, P. M., Ibekwe, V. I., Ekpono, E. U., Ugwu, P. C. and Okechukwu, 
P. C. Effect of ethanol extract of Cajanus cajan leaf on plasma lipid 
level in albino rats. Inter J Cur Res  Acad Rev. 2015; 3(1): 161-167. 
 
